Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 5/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8073073 | 1.00 | NAAA (0.53) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL13797805 | 1.00 | NAAA (0.53) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL13496604 | 1.00 | NAAA (0.53) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL28214264 | 1.00 | NAAA (0.53) | NAAAEPHX1NOD1TSHRHTR2C | |
| Hydrochloric Acid SCHEMBL8073071 | 0.98 | NAAA (0.52) | NAAAEPHX1NOD1TSHRHTR2C | |
| Hydrochloric Acid SCHEMBL27687913 | 0.98 | NAAA (0.52) | NAAAEPHX1NOD1TSHRHTR2C | |
| Hydrochloric Acid SCHEMBL215954 | 0.98 | NAAA (0.52) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL5309795 | 0.98 | NAAA (0.50) | NAAAEPHX1NOD1TSHRHTR2C | |
| SCHEMBL2734881 | 0.92 | ALDH1A1 (0.52) | NAAAEPHX1NOD1TSHRHCAR2 | |
| SCHEMBL2734865 | 0.92 | ALDH1A1 (0.52) | NAAAEPHX1NOD1TSHRHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101816664-B | Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases | GILEAD SCIENCES INC | 2012-04-18 | — | — | CN | disclosed |
| US-8088754-B2 | Anti-proliferative compounds, compositions, and methods of use thereof | GILEAD SCIENCES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| CN-101816664-A | The phosphonate ester, mono phosphonic acid amidate, the two phosphonic acid amide thing that are used for the treatment of viral disease | GILEAD SCIENCES INC | 2010-09-01 | — | — | CN | disclosed |
| EP-2204374-A1 | Nucleoside phosphonates and analogs thereof for the treatment of HPV-infections | GILEAD SCIENCES, INC. (US) | 2010-07-07 | — | — | EP | disclosed |
| US-20090149400-A1 | ANTI-PROLIFERATIVE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF | GILEAD SCIENCES, INC. (US) | 2009-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149400-A1 | ANTI-PROLIFERATIVE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF | CCNY, CCNO, CCNB3 | NAAA 4650/4885EPHX1 1036/4885NOD1 1383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.